| Q91973479 | A Path Toward Precision Medicine for Neuroinflammatory Mechanisms in Alzheimer's Disease |
| Q44182830 | Aberrant expression of NOS isoforms in Alzheimer's disease is structurally related to nitrotyrosine formation |
| Q42471249 | Acceleration of ageing-related gliopathic changes and hippocampal dysfunction following intracerebroventricular infusion of cysteamine in adult rats |
| Q24815912 | Activation of microglial NADPH oxidase is synergistic with glial iNOS expression in inducing neuronal death: a dual-key mechanism of inflammatory neurodegeneration |
| Q34361321 | Adaptative responses of spinal astrocytes to oxidative stress |
| Q36072445 | Age and region-specific responses of microglia, but not astrocytes, suggest a role in selective vulnerability of dopamine neurons after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure in monkeys |
| Q48722711 | Altered apolipoprotein E secretion in cytokine treated human astrocyte cultures |
| Q48456362 | Amyloid-beta peptide activates cultured astrocytes: morphological alterations, cytokine induction and nitric oxide release |
| Q48341086 | Annual review prize lecture cytokines - killers in the brain? |
| Q48090493 | Antenatal corticosteroids and cranial ultrasonographic abnormalities |
| Q46056417 | Anti-inflammatory effects of daidzein on primary astroglial cell culture |
| Q98471220 | Antifungal drug miconazole ameliorated memory deficits in a mouse model of LPS-induced memory loss through targeting iNOS |
| Q34199042 | Arginine metabolism and the synthesis of nitric oxide in the nervous system |
| Q48589023 | Astrocytic activation and delayed infarct expansion after permanent focal ischemia in rats. Part I: enhanced astrocytic synthesis of s-100beta in the periinfarct area precedes delayed infarct expansion |
| Q48345028 | Benzodiazepines, glia, and HIV-1 neuropathogenesis |
| Q60960149 | Birth and Neonatal Transition in the Guinea Pig: Experimental Approaches to Prevent Preterm Birth and Protect the Premature Fetus |
| Q36299169 | C/EBPβ regulates multiple IL-1β-induced human astrocyte inflammatory genes |
| Q39507440 | CD4(+) lymphocyte-mediated suppression of cytomegalovirus expression in human astrocytes. |
| Q50223200 | CNS inflammation and neurodegeneration |
| Q39742087 | CXCL10 production from cytomegalovirus-stimulated microglia is regulated by both human and viral interleukin-10. |
| Q36449877 | Can infections cause Alzheimer's disease? |
| Q46947013 | Changes in iNOS, GFAP and NR1 expression in various brain regions and elevation of sphingosine-1-phosphate in serum after immobilized stress |
| Q33971397 | Changes in the NMR metabolic profile of human microglial cells exposed to lipopolysaccharide or morphine |
| Q36418584 | Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis |
| Q44388392 | Cyclooxygenase-2 mediates platelet-activating factor-induced prostaglandin E2 release from rat primary astrocytes |
| Q79424104 | Cytochemical alterations in the rat retina by LPS administration |
| Q73231035 | Cytokine-mediated neuronal apoptosis |
| Q56965208 | Cytomegalovirus induces cytokine and chemokine production differentially in microglia and astrocytes: Antiviral implications |
| Q48275893 | Dependence of neurones on astrocytes in a coculture system renders neurones sensitive to transforming growth factor beta1-induced glutamate toxicity |
| Q80990228 | Differential activation of astrocytes by innate and adaptive immune stimuli |
| Q45963433 | Effect of concurrent chronic exposure of fluoride and aluminum on rat brain. |
| Q44014878 | Effects of IL6 and IL1beta on aFGF expression and excitotoxicity in NT2N cells |
| Q48658688 | Effects of pro-inflammatory cytokines in experimental spinal cord injury |
| Q37296697 | Efficient subtractive cloning of genes activated by lipopolysaccharide and interferon γ in primary-cultured cortical cells of newborn mice |
| Q36897350 | Enhancement of beta-amyloid precursor protein transcription and expression by the soluble interleukin-6 receptor/interleukin-6 complex. |
| Q34142783 | Excess neutrophil infiltration during cytomegalovirus brain infection of interleukin-10-deficient mice |
| Q73226709 | Expression of cytokine genes and increased nuclear factor-kappa B activity in the brains of scrapie-infected mice |
| Q53243973 | Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: evidence for an induction by amyloid pathology. |
| Q35791396 | Expression of glia maturation factor in neuropathological lesions of Alzheimer's disease |
| Q48931506 | Expression of inducible nitric oxide synthase, interleukin-1 and caspase-1 in HIV-1 encephalitis |
| Q74271482 | Extracellular accumulation of nitric oxide, hydrogen peroxide, and glutamate in astrocytic cultures following glutathione depletion, complex I inhibition, and/or lipopolysaccharide-induced activation |
| Q48230911 | FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells. |
| Q35609009 | Glaucomatous optic neuropathy: when glia misbehave |
| Q48290868 | Glial glutamate transport as target for nitric oxide: consequences for neurotoxicity |
| Q28307030 | Glial modulators as potential treatments of psychostimulant abuse |
| Q48088015 | Glial-derived proteins activate cultured astrocytes and enhance beta amyloid-induced glial activation |
| Q48157249 | Gp-41-mediated astrocyte inducible nitric oxide synthase mRNA expression: involvement of interleukin-1beta production by microglia |
| Q35891392 | HIV-1-infected and/or immune activated macrophages regulate astrocyte SDF-1 production through IL-1beta |
| Q42414305 | Hemin inhibits NO production by IL-1β-stimulated human astrocytes through induction of heme oxygenase-1 and reduction of p38 MAPK activation |
| Q57925075 | Hypertension Increases Retinal Inflammation in Experimental Diabetes: A Possible Mechanism for Aggravation of Diabetic Retinopathy by Hypertension |
| Q61449883 | Impact of Caffeine Consumption on Type 2 Diabetes-Induced Spatial Memory Impairment and Neurochemical Alterations in the Hippocampus |
| Q44086444 | Increase in glutamate-induced neurotoxicity by activated astrocytes involves stimulation of protein kinase C. |
| Q44163162 | Increased vulnerability of dopaminergic neurons in MPTP-lesioned interleukin-6 deficient mice |
| Q43962638 | Inducible nitric oxide synthase and argininosuccinate synthetase: co-induction in brain tissue of patients with Alzheimer's dementia and following stimulation with beta-amyloid 1-42 in vitro |
| Q39210271 | Inducible nitric oxide synthase expression is increased in the brain in fatal cerebral malaria |
| Q48337097 | Inducible nitric oxide synthase expression is selectively induced in astrocytes isolated from adult human brain |
| Q34646858 | Infiltrating regulatory B cells control neuroinflammation following viral brain infection |
| Q28138617 | Inflammation and Alzheimer's disease |
| Q44144035 | Inflammation is a component of neurodegeneration in response to Venezuelan equine encephalitis virus infection in mice |
| Q43715908 | Inflammatory neurodegeneration mediated by nitric oxide from activated glia-inhibiting neuronal respiration, causing glutamate release and excitotoxicity. |
| Q35170207 | Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria |
| Q35815842 | Inhibition of System Xc(-) Transporter Attenuates Autoimmune Inflammatory Demyelination |
| Q30726633 | Interleukin-1beta activates forebrain glial cells and increases nitric oxide production and cortical glutamate and GABA release in vivo: implications for Alzheimer's disease. |
| Q41554782 | Interrelationships between astrocyte function, oxidative stress and antioxidant status within the central nervous system. |
| Q41767433 | L-arginine and Alzheimer's disease. |
| Q37425401 | Minocycline bart |
| Q60683593 | Modulation of NADPH-diaphorase and glial fibrillary acidic protein by progesterone in astrocytes from normal and injured rat spinal cord |
| Q37270004 | Modulation of brain hemichannels and gap junction channels by pro-inflammatory agents and their possible role in neurodegeneration |
| Q36579852 | Neprilysin: an enzyme candidate to slow the progression of Alzheimer's disease |
| Q37772809 | Neuroinflammatory processes in Alzheimer's disease |
| Q43736972 | Neuronal and glial coexpression of argininosuccinate synthetase and inducible nitric oxide synthase in Alzheimer disease |
| Q44239981 | Neuronal and inducible nitric oxide synthase immunoreactivity following serotonin depletion |
| Q73081945 | Neuronal death, not axonal degeneration, results in significant gliosis within the cochlear nucleus of adult chickens |
| Q44208206 | Nitric oxide induces rapid, calcium-dependent release of vesicular glutamate and ATP from cultured rat astrocytes |
| Q33540925 | Nitric oxide, mitochondria and neurological disease |
| Q35051331 | Nitric oxide-induced mitochondrial dysfunction: implications for neurodegeneration |
| Q34361337 | Nitric oxide-mediated mitochondrial impairment in neural cells: a role for glucose metabolism in neuroprotection |
| Q33693579 | Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma |
| Q34025047 | PARP1 enhances inflammatory cytokine expression by alteration of promoter chromatin structure in microglia |
| Q48105656 | Peroxynitrite mediated damage and lowered superoxide tolerance in primary cortical glial cultures after induction of the inducible isoform of NOS. |
| Q42454440 | Potassium-stimulated taurine release and nitric oxide synthase activity during quinolinic acid lesion of the rat striatum |
| Q42981988 | Production, regulation and role of nitric oxide in glial cells |
| Q41097625 | Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells |
| Q46887871 | Protective action of neuronal nitric oxide synthase inhibitor in the MPTP mouse model of Parkinson's disease |
| Q48423531 | Protective effect of diphenyl diselenide on ischemia and reperfusion-induced cerebral injury: involvement of oxidative stress and pro-inflammatory cytokines |
| Q42252324 | Reactive oxygen species from human astrocytes induced functional impairment and oxidative damage |
| Q50126229 | Requirement for nitric oxide in retinal neuronal cell death induced by activated Müller glial cells |
| Q30426525 | Rett syndrome and other autism spectrum disorders--brain diseases of immune malfunction? |
| Q30702806 | Robust expression of TNF-alpha, IL-1beta, RANTES, and IP-10 by human microglial cells during nonproductive infection with herpes simplex virus. |
| Q36124489 | Role of formyl peptide receptor-like 1 (FPRL1/FPR2) in mononuclear phagocyte responses in Alzheimer disease |
| Q36516922 | Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia |
| Q36693990 | Roles of glia-derived cytokines on neuronal degeneration and regeneration |
| Q34297771 | Signaling and gene expression in the neuron-glia unit during brain function and dysfunction: Holger Hydén in memoriam |
| Q41530972 | Sixteenth Gaddum Memorial Lecture December 1996. Neuroimmune interactions: the role of cytokines |
| Q48534129 | Structural alterations and changes in cytoskeletal proteins and proteoglycans after focal cortical ischemia |
| Q48441907 | TGF-beta1 potentiates astrocytic nitric oxide production by expanding the population of astrocytes that express NOS-2. |
| Q48399673 | Taurine chloramine inhibits production of nitric oxide and prostaglandin E2 in activated C6 glioma cells by suppressing inducible nitric oxide synthase and cyclooxygenase-2 expression |
| Q73713043 | Temporal, regional, and cell-specific changes of iNOS expression after intrastriatal microinjection of interferon gamma and bacterial lipopolysaccharide |
| Q34386085 | The molecular bases of Alzheimer's disease and other neurodegenerative disorders |
| Q34361273 | The nitric oxide/cyclic GMP system in astroglial cells. |
| Q37095615 | The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective |
| Q48377406 | The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system |
| Q48534150 | Transient changes in the presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions |
| Q44332167 | Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration |
| Q38759253 | YKL-40 as a Potential Biomarker and a Possible Target in Therapeutic Strategies of Alzheimer's Disease |